Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzoyl-tyrosyl-paba
2. N-benzoyl-l-tyrosyl-p-aminobenzoic Acid
3. N-benzoyl-l-tyrosyl-paba
4. Paba-peptide
1. 37106-97-1
2. Btpaba
3. Chymex
4. Bz-tyr-4-abz-oh
5. Bentiromido
6. Bentiromidum
7. Btpaba, Pft
8. Btpaba Pft
9. Bentiromidum [inn-latin]
10. Bentiromido [inn-spanish]
11. Btpabapft
12. Btpaba-pft
13. Benzoyltyrosyl-p-aminobenzoic Acid
14. E-2663
15. Pft
16. Chebi:31263
17. 239if5w61j
18. N-benzoyl-l-tyrosyl-p-aminobenzoic Acid
19. (s)-p-(alpha-benzamido-p-hydroxyhydrocinnamamido)benzoic Acid
20. 4-(n-benzoyl-l-tyrosyl)aminobenzoic Acid
21. 4-[[(2s)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic Acid
22. (s)-4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic Acid
23. 4-[(2s)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic Acid
24. Benzoic Acid, 4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)-, (s)-
25. P-((n-benzoyl-l-tyrosin)amido)benzoic Acid
26. Brn 2910938
27. Ro 11-7891
28. Unii-239if5w61j
29. 4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic Acid
30. Bentiromide [usan:ban:inn:jan]
31. Bentiromide [usan:inn:ban:jan]
32. Einecs 253-349-8
33. Bt-paba
34. Bentiromide [mi]
35. Bentiromide [inn]
36. Bentiromide [jan]
37. Bentiromide [usan]
38. Bentiromide [vandf]
39. E 2663
40. Bentiromide [mart.]
41. Bentiromide [who-dd]
42. (s)-p-(.alpha.-benzamido-p-hydroxyhydrocinnamamido)benzoic Acid
43. Schembl151634
44. Chembl1200368
45. Dtxsid2048377
46. Bentiromide [orange Book]
47. Zinc608204
48. Hy-b1493
49. N-benzoyl-l-tyrosyl-p-aminobenzoate
50. Mfcd00055768
51. S4388
52. Ccg-268691
53. Db00522
54. 4-(n-benzoyl-l-tyrosyl)aminobenzoicacid
55. 4-(n-benzoyl-l-tyrosylamino)benzoic Acid
56. 4-[(n-benzoyl-l-tyrosyl)amino]benzoic Acid
57. Cs-0013190
58. Sw219774-1
59. Ab01566933_01
60. 106b971
61. Q793082
62. Sr-01000883958
63. Sr-01000883958-1
64. (s)-4-(2-benzamido-3-(4-hydroxyphenyl)propanamido)benzoic Acid
65. (4-[[(2s)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic Acid
| Molecular Weight | 404.4 g/mol |
|---|---|
| Molecular Formula | C23H20N2O5 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 404.13722174 g/mol |
| Monoisotopic Mass | 404.13722174 g/mol |
| Topological Polar Surface Area | 116 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 588 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Indicated as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy.
Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. The amount of p-aminobenzoic acid and its metabolites excreted in the urine is the quantitative measure of the chymotrypsin-secreting activity of the pancreas.
Indicators and Reagents
Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh's Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)
V - Various
V04 - Diagnostic agents
V04C - Other diagnostic agents
V04CK - Tests for pancreatic function
V04CK03 - Bentiromide
Primarily hepatic. Enzymatic activity capable of hydrolyzing bentiromide has also been found in normal small intestine.
Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. By determining the output of unchanged bentiromide in the urine following oral administration, it is possible to determine the sufficiency of pancreatic activity.
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Bentiromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bentiromide, including repackagers and relabelers. The FDA regulates Bentiromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bentiromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bentiromide supplier is an individual or a company that provides Bentiromide active pharmaceutical ingredient (API) or Bentiromide finished formulations upon request. The Bentiromide suppliers may include Bentiromide API manufacturers, exporters, distributors and traders.
click here to find a list of Bentiromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bentiromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Bentiromide active pharmaceutical ingredient (API) in detail. Different forms of Bentiromide DMFs exist exist since differing nations have different regulations, such as Bentiromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bentiromide DMF submitted to regulatory agencies in the US is known as a USDMF. Bentiromide USDMF includes data on Bentiromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bentiromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bentiromide suppliers with USDMF on PharmaCompass.
Bentiromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bentiromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bentiromide GMP manufacturer or Bentiromide GMP API supplier for your needs.
A Bentiromide CoA (Certificate of Analysis) is a formal document that attests to Bentiromide's compliance with Bentiromide specifications and serves as a tool for batch-level quality control.
Bentiromide CoA mostly includes findings from lab analyses of a specific batch. For each Bentiromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bentiromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Bentiromide EP), Bentiromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bentiromide USP).
LOOKING FOR A SUPPLIER?
